INKT
MiNK Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$9.74
-0.54 ▼ -5.25%
🌙 3월 13일 7:46 PM ET (한국 3/14 08:46)
$9.66
-0.08 ▼ -0.82%
| Index | - | P/E | - | EPS (ttm) | -3.03 | Insider Own | 64.83% | Shs Outstand | 0.00B | Perf Week | -5.25% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | -17.59% | Insider Trans | -0.07% | Shs Float | 0.00B | Perf Month | -11.86% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | -0.68 | Inst Own | 3.24% | Short Float | 2.25% | Perf Quarter | -23.55% |
| Income | -0.01B | P/S | - | EPS this Y | -7.34% | Inst Trans | 9.36% | Short Ratio | 0.13 | Perf Half Y | -33.52% |
| Sales | 0.00B | P/B | - | EPS next 5Y | -10.42% | ROA | -110.63% | Short Interest | 0.04M | Perf YTD | -12.65% |
| Book/sh | -2.94 | P/C | 3.2 | EPS past 3/5Y | 31.84% 16.86% | ROE | - | 52W High | -87.18% ($76.00) | Perf Year | 22.06% |
| Cash/sh | 3.04 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 53.63% ($6.34) | Perf 3Y | -55.12% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 21.48% | Gross Margin | - | Volatility(W/M) | 11.69% 5.23% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.99 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.08 | EPS Q/Q | -42.21% | Profit Margin | - | RSI (14) | 40.74 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.08 | Sales Q/Q | - | SMA20 | -11.77% ($11.04) | Beta | 0.36 | Target Price | $35 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -15.39% ($11.51) | Rel Volume | 0.4 | Prev Close | $10.28 |
| Employees | 23 | LT Debt/Eq | - | EPS/Sales Surpr. | 23.98% - | SMA200 | -24.61% ($12.92) | Avg Volume(3M) | 0.28M | Price | $9.74 |
| IPO | 2021/10/15 | Option/Short | No/Yes | Trades | 1124 | Volume | 112,642 | Change | -5.25% |
뉴스 로딩 중...